Get started
Author

Omar Mourad

Institution: McMaster University
ORCID: 0000-0003-4644-9121
Observed ORCID: 0000-0003-4644-9121
OpenAlex ID: A5039277608
Chikungunya: An Emerging Public Health Concern
2022 · Omar Mourad, Leila Makhani, et al. · Current Infectious Disease Reports · 82
PDF
Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review
2021 · Adam S. Komorowski, Anthony D. Bai, et al. · Clinical Microbiology and Infection · 13
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review
2023 · Carson K L Lo, Adam S Komorowski, et al. · Clinical Infectious Diseases · 6
PDF
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?
2021 · Adam S. Komorowski, Anthony D. Bai, et al. · Antimicrobial Agents and Chemotherapy · 4
In high-risk outpatients with COVID-19, remdesivir reduced COVID-19–related hospitalization or all-cause death at 28 d
2022 · Omar Mourad, Zain Chagla · Annals of Internal Medicine · 1
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?
2022 · Adam S Komorowski, Anthony D Bai, et al. · PubMed · 1
A Fatal Case of Rat-Bite Fever
2026 · Amanda YK. Cheung, Omar Mourad, et al. · JACC Case Reports
S3683 GAVE as the Presenting Sign of Systemic Sclerosis
2024 · Farha Shaikh, David Wan, et al. · The American Journal of Gastroenterology
Bartonella henselae Infection With Concurrent Latent Syphilis in a Patient With Unexplained Generalized Lymphadenopathy
2023 · Shannon Ying Gui, Omar Mourad, et al. · Infectious Diseases in Clinical Practice
Works count: 9
Citation count: 107
H-index: 4
I10-index: 2
Year
Topic
Type